Irwin M. Rosenthal
Direktor/Vorstandsmitglied bei EchoCath, Inc.
Profil
Irwin M.
Rosenthal is currently working as a Secretary at EchoCath, Inc. since 1995.
He has previously worked as a Director at SyntheMed, Inc. and Conversion Technologies International, Inc. and as a Partner at Greenberg Traurig LLP.
Aktive Positionen von Irwin M. Rosenthal
Unternehmen | Position | Beginn |
---|---|---|
EchoCath, Inc.
EchoCath, Inc. Medical SpecialtiesHealth Technology EchoCath, Inc. provides marketing medical devices, which enhance and expand the use of ultrasound technology for medical applications. It develops ultrasound technologies and characterizes blood flow and enables ultrasound imaging and identifying devices during interventional procedures such as needle biopsies and catheterizations. The company's technologies include a proprietary transcutaneous, epivascular and catheter based sensor and electronics system which provide data on the blood flow through internal vessels. EchoCath was founded on February 14, 1990 and is headquartered in Princeton, NJ. | Direktor/Vorstandsmitglied | 15.03.2010 |
Ehemalige bekannte Positionen von Irwin M. Rosenthal
Unternehmen | Position | Ende |
---|---|---|
Greenberg Traurig LLP
Greenberg Traurig LLP Miscellaneous Commercial ServicesCommercial Services Greenberg Traurig LLP provides legal services. The firm specializes in business aviation, futures and derivatives, financial regulatory and compliance, financial services litigation, project and infrastructure finance, public finance, restructuring, bankruptcy, and structured finance. The company was founded by Larry J. Hoffman, Mel Greenberg and Robert H. Traurig in 1967 and is headquartered in Miami, FL. | Corporate Officer/Principal | - |
Conversion Technologies International, Inc.
Conversion Technologies International, Inc. Industrial SpecialtiesProcess Industries Conversion Technologies International, Inc. develops, produces, and markets industrial abrasives. It also recycles glass used in televisions. The company was founded on August 20, 1997 and is headquartered in St. Augustine, FL. | Direktor/Vorstandsmitglied | - |
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
SyntheMed, Inc.
SyntheMed, Inc. Medical SpecialtiesHealth Technology SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ | Health Technology |
EchoCath, Inc.
EchoCath, Inc. Medical SpecialtiesHealth Technology EchoCath, Inc. provides marketing medical devices, which enhance and expand the use of ultrasound technology for medical applications. It develops ultrasound technologies and characterizes blood flow and enables ultrasound imaging and identifying devices during interventional procedures such as needle biopsies and catheterizations. The company's technologies include a proprietary transcutaneous, epivascular and catheter based sensor and electronics system which provide data on the blood flow through internal vessels. EchoCath was founded on February 14, 1990 and is headquartered in Princeton, NJ. | Health Technology |
Greenberg Traurig LLP
Greenberg Traurig LLP Miscellaneous Commercial ServicesCommercial Services Greenberg Traurig LLP provides legal services. The firm specializes in business aviation, futures and derivatives, financial regulatory and compliance, financial services litigation, project and infrastructure finance, public finance, restructuring, bankruptcy, and structured finance. The company was founded by Larry J. Hoffman, Mel Greenberg and Robert H. Traurig in 1967 and is headquartered in Miami, FL. | Commercial Services |
Conversion Technologies International, Inc.
Conversion Technologies International, Inc. Industrial SpecialtiesProcess Industries Conversion Technologies International, Inc. develops, produces, and markets industrial abrasives. It also recycles glass used in televisions. The company was founded on August 20, 1997 and is headquartered in St. Augustine, FL. | Process Industries |